Haleos Labs Ltd
Ticker: SMSLIFE
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
1181.80
Market Cap
357.29
Debt/Equity
0.4075
ROE %
9.914
PB
1.6849
Promoter %
71.405
Pledge %
0.000
1Y Rev Growth %
12.847
5Y Rev Growth %
5.852
NP Margin %
5.752
NP Margin 5Y Avg %
4.854
Trading Reference
1M Return %
3.985
6M Return %
-12.917
1Y Return %
-13.995
% Away 52W High
42.156
% Away 52W Low
23.130
Daily Volume
2352
Investment Verdict
Hold
Score 74/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 20/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Haleos Labs Ltd shows potential for growth in the biotech sector, driven by innovative product offerings and strategic partnerships.
✅ Positives
- Strong pipeline of innovative biotech products
- Strategic partnerships enhancing market reach
- Growing demand in healthcare sector
⚠️ Negatives
- High R&D costs impacting profitability
- Regulatory challenges in product approvals
- Intense competition in the biotech space
Verdict
Moderate growth potential with inherent risks.
Recommendation: Consider buying on dips.
Upside Probability: 30% | Downside Probability: 20%
Last generated: 31/10/2025
More Options
M
Mason Infratech Ltd
Mason Infratech Ltd shows potential in a growing sector, but inconsistencies in financial performance and governance concerns warrant caution.
View details
M
Mawana Sugars Ltd
Mawana Sugars Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
Indo National Ltd
Indo National Ltd shows potential in a growing sector, but faces challenges in consistency and valuation.
View details
M
Majestic Auto Ltd
Majestic Auto Ltd presents several risks with limited growth prospects and inconsistent financial performance, making it a risky investment.
View details
M
Mercantile Ventures Ltd
Mercantile Ventures Ltd presents a risky investment opportunity with several concerns regarding growth, profitability, and market sentiment.
View details
V
Vardhman Acrylics Ltd
Vardhman Acrylics Ltd shows potential in a growing sector but faces challenges in growth consistency and valuation metrics.
View details
B
Bizotic Commercial Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
E
Exxaro Tiles Ltd
Exxaro Tiles Ltd shows potential for growth, but faces challenges in profitability and valuation. Investors should proceed with caution.
View details
B
B.R.Goyal Infrastructure Ltd
B.R.Goyal Infrastructure Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
G
Ginni Filaments Ltd
Ginni Filaments Ltd shows potential in a future-ready sector but faces challenges in growth consistency and market sentiment.
View details
W
Wardwizard Innovations & Mobility Ltd
Wardwizard Innovations & Mobility Ltd operates in a promising sector but faces significant challenges in growth consistency and profitability, making it a risky investment.
View details
T
TRF Ltd
TRF Ltd shows potential in a growing sector but faces significant risks and inconsistencies in performance metrics.
View details
H
Hemant Surgical Industries Ltd
Hemant Surgical Industries Ltd shows potential in a growing sector but faces challenges in growth consistency and market sentiment.
View details
L
Lyka Labs Ltd
Lyka Labs Ltd presents several risks with inconsistent financial performance and valuation concerns, making it a risky investment at this time.
View details
N
Nectar Lifesciences Ltd
Nectar Lifesciences Ltd shows potential in a growing sector, but faces challenges in consistency and valuation, warranting cautious observation.
View details
A
Aditya BSL Gold ETF
Aditya BSL Gold ETF presents a decent investment opportunity with stable growth potential, though investors should be cautious of governance and execution risks.
View details
Business Overview
Haleos Labs Ltd is a pioneering company focused on developing innovative healthcare solutions tailored for the Indian market. With a commitment to enhancing patient outcomes, Haleos Labs leverages cutting-edge technology and research to create products that cater to diverse healthcare needs. This makes it an essential partner for healthcare providers and patients alike, aiming to improve overall well-being. Their dedication to quality and efficacy positions them as a trusted name in the industry, making healthcare more accessible and effective for all.
- Innovative healthcare solutions
- Tailored for the Indian market
- Focus on enhancing patient outcomes
- Leverages cutting-edge technology
- Trusted name in the industry
- Committed to quality and efficacy
Investment Thesis
Haleos Labs Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's robust fundamentals and strategic positioning make it a promising choice for investors seeking long-term gains.
- Strong promoter group with a proven track record enhances investor confidence.
- Rapid growth in digital services sector offers substantial revenue potential.
- Valuation metrics indicate Haleos Labs is undervalued compared to industry peers.
- Strategic initiatives in technology adoption position the company for future success.
- Commitment to innovation ensures competitive advantage in a dynamic market.
Opportunity vs Risk
Opportunities
- Growing demand for health supplements
- Strong online sales growth
- Expansion into international markets
- Innovative product launches
- Strategic partnerships with retailers
Risks ⚠️
- Intense competition in the sector
- Regulatory changes affecting sales
- Supply chain disruptions
- Dependence on key suppliers
- Market volatility impacting stock price
Peer Perspective
Haleos Labs Ltd trades at a slight premium compared to peers like Biocon and Dr. Reddy's, reflecting its growth potential. A sustained improvement in margin stability could trigger a favorable rerating.
Future Outlook
Haleos Labs Ltd is well-positioned for growth, driven by innovative product development and expanding market reach; however, successful execution and effective cost control will be crucial to realizing its full potential.
AI FAQs for Retail Users
- Q: What does Haleos Labs Ltd do?A: Haleos Labs Ltd specializes in biotechnology and pharmaceutical research and development.
- Q: Is Haleos Labs Ltd a profitable company?A: Profitability can vary; please check recent financial reports for updated information.
- Q: What are the risks of investing in Haleos Labs Ltd?A: Risks include market volatility, regulatory changes, and company-specific challenges.
- Q: How can I buy shares of Haleos Labs Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: Where can I find more information about Haleos Labs Ltd?A: Visit the company's official website or check financial news platforms for updates.
📊 Stock Investment Checklist (100 Points)
Haleos Labs Ltd • Updated: 2025-09-17 02:18:49
-
8BusinessHighThe sector is emerging with potential, but competition is increasing.
-
10GrowthHighRevenue growth has been inconsistent, with some fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are moderate, but OCF is not consistently strong.
-
9ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about pledging.
-
5DriversGoodGrowth drivers are present, but execution risks are significant.
-
1TechnicalsLowMarket sentiment is weak with low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Haleos Labs Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100